Identity
HGNC
LOCATION
20p13
LOCUSID
ALIAS
C20orf98,dJ1103G7.6
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 80023
MIM: 610666
HGNC: 16229
Ensembl: ENSG00000125841
Variants:
dbSNP: 80023
ClinVar: 80023
TCGA: ENSG00000125841
COSMIC: NRSN2
RNA/Proteins
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37365792 | 2024 | miR-488-3p Represses Malignant Behaviors and Facilitates Autophagy of Osteosarcoma Cells by Targeting Neurensin-2. | 0 |
| 38457049 | 2024 | LncRNA LUESCC promotes esophageal squamous cell carcinoma by targeting the miR-6785-5p/NRSN2 axis. | 1 |
| 37365792 | 2024 | miR-488-3p Represses Malignant Behaviors and Facilitates Autophagy of Osteosarcoma Cells by Targeting Neurensin-2. | 0 |
| 38457049 | 2024 | LncRNA LUESCC promotes esophageal squamous cell carcinoma by targeting the miR-6785-5p/NRSN2 axis. | 1 |
| 35662041 | 2022 | E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway. | 1 |
| 35662041 | 2022 | E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway. | 1 |
| 27908706 | 2017 | Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer. | 7 |
| 27908706 | 2017 | Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer. | 7 |
| 26045763 | 2015 | NRSN2 promotes non-small cell lung cancer cell growth through PI3K/Akt/mTOR pathway. | 8 |
| 26055238 | 2015 | Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma. | 12 |
| 26045763 | 2015 | NRSN2 promotes non-small cell lung cancer cell growth through PI3K/Akt/mTOR pathway. | 8 |
| 26055238 | 2015 | Down-Regulated NRSN2 Promotes Cell Proliferation and Survival Through PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma. | 12 |
| 24019301 | 2013 | SOX12 and NRSN2 are candidate genes for 20p13 subtelomeric deletions associated with developmental delay. | 8 |
| 24019301 | 2013 | SOX12 and NRSN2 are candidate genes for 20p13 subtelomeric deletions associated with developmental delay. | 8 |
| 19824122 | 2009 | Decreased expression of Neurensin-2 correlates with poor prognosis in hepatocellular carcinoma. | 12 |
Citation
Dessen P
NRSN2 (neurensin 2)
Atlas Genet Cytogenet Oncol Haematol. 2008-07-01
Online version: http://atlasgeneticsoncology.org/gene/50216/nrsn2
